Tomoverse Imaging Inc. Announces Closing of $5 Million Dollar Seed Funding Round Led by Strategic Canadian Family Office
Saturday, July 19, 2025
MONTRÉAL, July 11, 2025 /PRNewswire/ - Tomoverse Imaging Inc., a medical software company pioneering advanced CT imaging solutions for structural heart interventions, today announced the successful closing of its $5M Seed funding round, led by a prominent Canadian Family Office.
This funding milestone marks a significant advancement for Tomoverse, developer of tvCT, a flagship platform designed to modernize and streamline planning and execution of complex transcatheter cardiac procedures. Built by physicians for physicians, tvCT provides intuitive, high-performance tools that enable clinicians to enhance patient care and optimize procedural outcomes. The platform integrates advanced AI-based automated capabilities, significantly improving accuracy and efficiency in clinical workflows.
The capital raised will be directed toward completing software development, advancing clinical studies, and securing regulatory clearances from the U.S. Food and Drug Administration (FDA), Health Canada, and other global regulatory bodies. Additionally, the funding supports Tomoverse's strategic commercialization efforts in North America and key international markets.
"We are deeply grateful for the trust and confidence placed in us by our investors," said Stuart Kozlick, CEO of Tomoverse Imaging Inc. "This strategic investment accelerates our product roadmap, enabling us to bring our innovative technology closer to patients and clinicians who need it most."
Tomoverse aims to become the global standard in CT imaging solutions for structural heart interventions -- a rapidly growing sector transforming patient care and procedural efficiency worldwide.
About Tomoverse Imaging Inc.
Tomoverse Imaging Inc. (www.tomoverse.tech) is a Montreal-based medical software company specializing in advanced cardiac CT imaging solutions for structural heart and coronary interventions. Its flagship platform, tvCT, delivers intuitive, cloud-based tools that enhance procedural planning, improve clinical outcomes, and support education and research in interventional cardiology. Founded by leaders in cardiology, computational imaging, and medtech innovation, Tomoverse is dedicated to transforming how clinicians plan and execute complex heart procedures worldwide.
Caution: the tvCT software platform is not approved and not for sale in any geography.
View original content to download multimedia:https://www.prnewswire.com/news-releases/tomoverse-imaging-inc-announces-closing-of-5-million-dollar-seed-funding-round-led-by-strategic-canadian-family-office-302503031.html
SOURCE Tomoverse Imaging
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
|
